Alliqua BioMedical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Alliqua BioMedical generated cash of -$9,710,000, which is more than the previous year. Cash used in financing activities reached the amount of -$12,891,000 last year. Net change in cash is therefore $6,699,000.
Cash Flow
| 2010 | -1.71B | 1.37B | 1.55B |
|---|---|---|---|
| 2011 | -2.19B | 73.20M | 990M |
| 2012 | -1.96B | -86.18M | 2.05B |
| 2013 | -4.76M | -118.06K | 16.72M |
| 2014 | -13.29M | -2.33M | 20.30M |
| 2015 | -21.61M | -15.37M | 46.30M |
| 2016 | -18.33M | 2.21M | -4.37M |
| 2017 | -10.67M | 3.88M | 3.39M |
| 2018 | -9.71M | 29.3M | -12.89M |
ALQA Cash Flow Statement (2010 – 2018)
| 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 2.18M | 5.58M | 26.08M | 16.77M | 12.10M | 260.35K | 260.11M | 1.39B | 179.69M |
Operating activities | |||||||||
Net income | -8.41M | -25.70M | -28.24M | -26.01M | -25.44M | -21.97M | -4.90B | -13.85B | -3.09B |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 2.15M | 6.28M | 5.13M | 3.42M | 1.07M | 673.53K | 647.81M | 632.69M | 624.44M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 4.20M | 1.42B | 1.67B | 531.45M |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 4.20M | 1.42B | 1.67B | 531.45M |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 3.15M | -621K | -281K | -779.47K | -800.19K | -47.96K | -41.09M | 55.15M | 97.75M |
Inventories | -120K | 792K | -113K | -1.43M | -437.83K | -241.07K | 17.65M | -188K | 188K |
Accounts payable | -2.39M | -627K | 2.68M | -639.27K | 826.65K | 977.59K | 525.67M | 45.38M | 156.35M |
Cash generated by operating activities | -9.71M | -10.67M | -18.33M | -21.61M | -13.29M | -4.76M | -1.96B | -2.19B | -1.71B |
Investing activities | |||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 333.33K | -51.4M | -86.18M | -164.72M | -53.59M |
Acquisitions Net | 0 | 0 | 0 | -14.94M | -1.99M | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 29.3M | 3.88M | 2.21M | -15.37M | -2.33M | -118.06K | -86.18M | 73.20M | 1.37B |
Financing activities | |||||||||
Common Stock Issued | 0 | 5.84M | 0 | 32.19M | 14.37M | 15.79M | 0 | 990M | 1.55B |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -8.88M | -2.18M | -5.58M | -26.08M | -16.77M | -12.10M | 0 | 0 | 0 |
Repayments of term debt | -14.13M | 0 | -1.74M | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -12.89M | 3.39M | -4.37M | 46.30M | 20.30M | 16.72M | 2.05B | 990M | 1.55B |
Net Change In Cash | 6.69M | -3.39M | -20.5M | 9.30M | 4.67M | 11.84M | 246K | -1.13B | 1.21B |
Cash at end of period | 8.88M | 2.18M | 5.58M | 26.08M | 16.77M | 12.10M | 260.35M | 260.11M | 1.39B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |